Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

 

http://securities.stanford.edu/news-archive/2003/20030612_Headline06_Oppel.htm

 

2003 News and Press Releases


 

News News 2003


HEADLINE:

House Expected To Pass Bill To Rewrite The Rules On Class-Action Lawsuits
By: Richard A. Oppel Jr.


The New York Times. June 12, 2003

_________________________________________________________________________

EXCERPT: The House is poised to pass a bill that would give corporate lobbyists one of their most sought-after goals on Capitol Hill: a sweeping rewrite of the rules governing class-action lawsuits. Business groups, which have been pushing for the legislation for years, want to force many large class-action suits into federal courts and out of the state courts favored by plaintiffs' lawyers. A broad array of industry groups that have been socked by big class-action lawsuits, including health insurance companies and life insurers, argue that the system is being abused by lawyers who increasingly file major cases in a few out-of-the-way jurisdictions that have sympathetic judges and juries. Trial lawyers, as well as some environmental and consumer groups, contend the proposals would weaken a tool for protecting the interests of consumers, and they argue that companies want the legislation so they can push big cases into courts that tend to be friendlier to corporate defendants. The real battle over the bill is in the Senate, where many Democrats have ties to the powerful trial lawyers' lobby. But backers of the legislation are more optimistic than in years past, saying they are only a few votes short of obtaining the 60 needed to force a vote on the Senate floor, a tally that partly reflects Republican gains in elections last year. The House, which has approved similar legislation before, is scheduled to vote on Thursday. Because the legislation applies retroactively to many lawsuits and also includes a provision granting mandatory appeals of class-action certification rulings, the bill could cause delays in pending federal-court cases that seek to recover money lost through the corporate scandals at Enron and other large companies. The legislation is also promoted as a remedy for what critics on both sides describe as collusive settlements between lawyers and companies. In these pacts, the lawyers get big fees, but only a few dollars or worthless coupons are provided to each plaintiff. At the same time, the settlements allow corporate defendants to wipe out liabilities they face for fraud, defective products and other claims. But whether this legislation will curb collusive settlements has become a hotly contested point. Business groups say the provisions they favor will subject settlements to new scrutiny, but critics call the provisions weak and say that lobbyists are resisting a more serious repair to the problem because corporations want to continue using coupons in settlements.


Copyright © 2001
Stanford Law School


 

 

 

 

Return to Vaccination News Home Page

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.